Physician profile
Curtis E Harris
NPI 1235116013
$124,824.82
in general payments reported to CMS, 2019-2025
12 companies · $97.02 in 2025
The $97.02 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $91K · 2020: $33K · 2021: $545 · 2022: $90.11 · 2023: $57.72 · 2024: $69.64 · 2025: $97.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $224.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $224.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $124,396.82 | 2019-2021 | |
| Novo Nordisk INC | $126.39 | 2019-2025 | Saxenda, Wegovy, Rybelsus |
| Xeris Pharmaceuticals, INC. | $97.19 | 2022-2025 | Gvoke Hypopen |
| Sanofi-Aventis U.S. LLC | $48.63 | 2019-2025 | |
| Lilly USA, LLC | $38.64 | 2019-2025 | Zepbound, Mounjaro |
| Sequel Med Tech, LLC | $21.44 | 2025 | Twiist |
| Bayer Healthcare Pharmaceuticals INC. | $19.11 | 2024 | |
| Novartis Pharmaceuticals Corporation | $18.91 | 2024 | |
| Abbott Laboratories | $16.53 | 2024 | Freestyle Libre 3 |
| Horizon Therapeutics Plc | $14.41 | 2022 | |
| Dexcom, INC. | $14.05 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Curtis Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.